echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > 9-year follow-up to China's chronic disease prospective study: 40% of stroke patients relapse within 5 years

    9-year follow-up to China's chronic disease prospective study: 40% of stroke patients relapse within 5 years

    • Last Update: 2020-05-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The results of the 9-year follow-up study of China's chronic disease, which covered 500,000 adults, showed that the risk of stroke recurrence or death was high within 5 years of the first stroke in China40 percent of patients who survived 28 days after the first stroke had a recurrence of a stroke and 17 percent of deaths in five yearsresearchers point out that despite the significant progress made in stroke treatment in China, the short-term and long-term prognosis of patients is still poor, so further improvement of secondary prevention of stroke is urgently needed to reduce the risk of recurrence and deathat the same time, stroke prevention still needs to be strengthened, mainly lifestyle regulationthe study showed that in the first stroke in China, the 28-day mortality rate of cerebral hemorrhage patients was as high as 47%, of which the 28-day mortality rate in patients with subcranytosis hemorrhage was 19%, and the mortality rate for 28 days in patients with stroke to be classified was 24% and in ischemic stroke patients 3%the gap between urban and rural areas is very obvious, with cobweb lower cavity bleeding as the 28-day mortality rate of urban and rural patients at 32% and 52%, respectivelyin China's first stroke, 28 days when the survival of patients, 5 years of stroke recurrence rate of 41%, of which ischemic stroke, cerebral hemorrhage, cobweb lower cavity hemorrhage, to be classified stroke patients relapsed rate of 41%, 44%, 22%, 40%the five-year mortality rate was 17% among all patients who survived the first stroke 28 days, the five-year mortality rate was highest in patients with cerebral hemorrhage, at 28%, with a 5-year mortality rate of 16% for patients with subcranytosis haemorrhage, and 16% for patients with ischemic stroke and 15% for patients with a typed strokeThe estimated cumulative incidence of stroke recurrence (A), major vascular events (B), vascular death (C), and all-cause death (D) occurred in patients with different types of stroke 28 days after the first stroke, and 91% of stroke recurrence types were still not ischemic stroke sympathies in patients with first strokein patients with first-on-the-brain haemorrhage, 56% of stroke recurrences were still brain haemorrhages, but 41% were ischemic strokesA total of 512,715 adults aged 35 to 74 were included in the China Chronic Disease Prospective Study, of whom 489,586 had no ischemic heart disease or stroke and were followed for 9 yearsDuring thestudy period of the, 45,732 people (9.3%) had their first stroke, with ischemic stroke, cerebral hemorrhage, subcranytosis bleeding, and subcranytosis stroke accounting for 80%, 16%, 2% and 2% respectivelyThe average age of stroke patientsand those who did not have a stroke was 59.3 years and 50.8 years, respectively source: s 1 s mortality and recurrent adult events after first incident stroke: a 9-year community-based study of 0.5 million Chinese adults The Lancet Global Health, 2020, 8 (40): PE580-E590 Wang Yide, Liu Jianmin, Yang Wei, etc China's stroke prevention and control still faces great challenges - China Stroke Prevention and Control Report 2018 Summary.China Circulation Journal, 2019, 34: 105-119.
    Author: Zhu Zhu Source:
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.